206559-40-2

Usage

Uses

Used in Pharmaceutical Industry:
5-Bromo-2-chloro-m-xylene is used as a key intermediate in the synthesis of various pharmaceutical compounds for its unique reactivity and properties, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Bromo-2-chloro-m-xylene serves as a crucial building block in the production of agrochemicals, aiding in the creation of effective pesticides and other agricultural chemicals to protect crops and enhance yields.
Used in Organic Compounds Synthesis:
5-Bromo-2-chloro-m-xylene is utilized as a versatile starting material in the synthesis of a wide range of organic compounds, leveraging its unique chemical structure to form diverse products with specific applications across various industries.
Used as a Solvent in Industrial Processes:
Due to its properties, 5-Bromo-2-chloro-m-xylene is also employed as a solvent in certain industrial processes, where its ability to dissolve other substances and participate in chemical reactions is advantageous for specific applications.

InChI:InChI=1/C8H8BrCl/c1-5-3-7(9)4-6(2)8(5)10/h3-4H,1-2H3

Upstream product

• 556-96-7 5-bromo-1,3-xylene 
• 24596-19-8 4-bromo-2,6-dimethylphenylamine 

Downstream Products

• 866087-01-6 2-acetylamino-3-(4-chloro-3,5-dimethyl-phenyl)-acrylic acid methyl ester 
• 1231647-28-1 2-bromo-4-(4-chloro-3,5-dimethylphenyl)-5-methylindene 
• 90649-78-8 4-chloro-3,5-dimethylbenzenecarboxylic acid 
• 1231647-26-9 4-(4-chloro-3,5-dimethylphenyl)-5-methylindene 
• 1231647-31-6 dimethylbis[2-{2-(5-methylfuryl)}-4-(4-chloro-3,5-dimethylphenyl)-5-methylindenyl]silane 
• 1231647-29-2 2-{2-(5-methylfuryl)}-4-(4-chloro-3,5-dimethylphenyl)-5-methylindene 

Relevant academic research and scientific papers

The Precise Synthesis of Phenylene-Extended Cyclic Hexa-peri-hexabenzocoronenes from Polyarylated [n]Cycloparaphenylenes by the Scholl Reaction

The longitudinal extension of cycloparaphenylenes (CPP) towards ultrashort carbon nanotubes (CNTs) is essential for the solution based bottom-up synthesis of CNTs. Herein, the longitudinal extension of the CPP skeleton by the introduction of hexaphenylbenzene units towards polyarylated [n]CPPs is described. Further, the applicability of the Scholl reaction to selectively form graphenic sidewalls is demonstrated. The ring size and substitution patterns of the polyarylated [n]CPPs were varied to overcome strain-induced side reactions during the oxidative cyclodehydrogenation and cyclic para-hexa-peri-hexabenzocoronene trimers ([3]CHBCs) were selectively obtained. This concept is envisioned as an access to ultrashort carbon nanotubes subject to the condition that further benzene rings with the right connectivity will be inserted.

N-SULFONYL BENZAMIDE DERIVATIVE WITH HETEROCYCLIC SUBSTITUENT, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF

The present invention discloses an N-sulfonyl benzamide derivative with a heterocyclic substituent, and a preparation method therefor and a pharmaceutical application thereof. More specifically, the invention discloses a compound represented by formula (II) or a pharmaceutically acceptable salt, stereoisomer, solvent compound, or prodrug thereof, and a preparation method therefor and an application thereof. Refer to the specification for definitions of each group in the formula.

METALLOCENE COMPLEX AND METHOD FOR POLYMERIZING OLEFIN

A metallocene complex by which high uptake efficiency of ethylene and/or α-olefin can be obtained compared with the conventional metallocene catalyst, and rubber component having high molecular weight can be polymerized, and polymerization method of olefi

SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS

The invention relates to CGRP antagonists of general formula (I), in which A, X, D, E, G, M, Q and R1 to R3 are defined as in Claim 1, to their tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures and their salts as well as the hydrates of the salts, particularly their physiologically compatible salts having inorganic or organic acids, to medicaments containing these compounds, to their use, and to methods for the production thereof.